Craneware plc Grant of Options (7265J)
13 September 2016 - 11:48PM
UK Regulatory
TIDMCRW
RNS Number : 7265J
Craneware plc
13 September 2016
Craneware plc
("Craneware", "the Group" or the "Company")
Grant of Options
13 September 2016 - The Board of Craneware plc (AIM: CRW.L), the
market leader in Value Cycle solutions for the US healthcare
market, announces that on 12 September 2016, the Remuneration
Committee approved the granting of share options to certain
Directors to subscribe for ordinary shares of 1p each in the
Company as follows:
Director No. of options Percentage of
granted issued share capital
Keith Neilson
(CEO) 28,628 0.14
The above options have been granted at an exercise price of
1177.5p per share (being the closing market price on 12 September
2016). These options will be subject to performance criteria, such
that they vest in three equal tranches over three years. One third
of the share options will vest on or after 30 June 2017, one third
on or after 30 June 2018 and the final third on or after 30 June
2019. The share options will not become exercisable until three
years from the date of the grant.
For further information, please contact:
Craneware plc Peel Hunt Alma
+44 (0)131 550 +44 (0)20 7418 +44 (0)208 004
3100 8900 4218
Keith Neilson, Dan Webster Caroline Forde ,
CEO
Craig Preston, Adrian Trimmings Hilary Buchanan
CFO George Sellar Robyn McConnachie
About Craneware
Craneware enables healthcare providers to improve margins and
enhance patient outcomes so they can continue to provide quality
outcomes for all.
Craneware is the leader in automated value cycle solutions that
help US provider organisations discover, convert and optimise
assets to achieve best clinical outcomes and financial performance.
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland
with offices in Atlanta, Boston and Phoenix employing over 200
staff. Craneware's market-driven, SaaS solutions normalise
disparate data sets, bringing in up-to-date regulatory and
financial compliance data to deliver value at the points where
clinical and operational data transform into financial
transactions, creating actionable insights that enable informed
tactical and strategic decisions. To learn more, visit
craneware.com and thevaluecycle.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEADNDFLLKEFF
(END) Dow Jones Newswires
September 13, 2016 09:48 ET (13:48 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024